XML 150 R127.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule I - Condensed Financial Information of Registrant (Parent Company Only) - Condensed Statements of Financial Condition (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
ASSETS        
Cash and cash equivalents $ 1,308,218 $ 971,316 $ 1,234,773  
Investments in subsidiaries, equity method 16,899 0    
Deferred tax assets 479,582 497,340    
Other assets 347,558 414,518    
Total Assets 4,793,993 4,635,781    
Liabilities:        
Other liabilities 606,526 546,947    
Total Liabilities 4,029,210 4,065,919    
Commitments and contingencies    
STOCKHOLDERS’ EQUITY        
Preferred stock, par value $.01 per share; 15,000,000 shares authorized; no shares issued and outstanding at December 31, 2024 and 2023 0 0    
Common stock:        
Par value $.01 per share (500,000,000 shares authorized; 112,766,091 shares issued at December 31, 2024 and 2023, including shares held by subsidiaries) 1,128 1,128    
Additional paid-in-capital 327,810 247,204    
Retained earnings 1,472,113 1,402,636    
Accumulated other comprehensive loss, net of tax (326,742) (289,950)    
Stockholders' equity subtotal before common stock held by subsidiaries and Noncontrolling interests 1,474,309 1,361,018    
Common stock held by subsidiaries, at cost (22,467,315 and 25,340,287 shares at December 31, 2024 and 2023, respectively) (838,069) (937,259)    
Total Lazard Stockholders’ Equity 636,240 423,759    
Total Liabilities, Redeemable Noncontrolling Interests and Stockholders’ Equity 4,793,993 4,635,781    
Parent Company        
ASSETS        
Cash and cash equivalents 1,049 1,901 $ 709 $ 1,208
Investments in subsidiaries, equity method 634,732 (1,402,500)    
Deferred tax assets 1,192 0    
Other assets 1,052 0    
Total Assets 638,250 424,183    
Liabilities:        
Other liabilities 179 424    
Total Liabilities 2,010 424    
Commitments and contingencies    
STOCKHOLDERS’ EQUITY        
Preferred stock, par value $.01 per share; 15,000,000 shares authorized; no shares issued and outstanding at December 31, 2024 and 2023 0 0    
Common stock:        
Par value $.01 per share (500,000,000 shares authorized; 112,766,091 shares issued at December 31, 2024 and 2023, including shares held by subsidiaries) 1,128 1,128    
Additional paid-in-capital 327,810 247,204    
Retained earnings 1,472,113 1,402,636    
Accumulated other comprehensive loss, net of tax (326,742) (289,950)    
Stockholders' equity subtotal before common stock held by subsidiaries and Noncontrolling interests 1,474,309 1,361,018    
Common stock held by subsidiaries, at cost (22,467,315 and 25,340,287 shares at December 31, 2024 and 2023, respectively) (838,069) (937,259)    
Total Lazard Stockholders’ Equity 636,240 423,759    
Total Liabilities, Redeemable Noncontrolling Interests and Stockholders’ Equity 638,250 424,183    
Parent Company | Subsidiaries of Lazard Ltd        
ASSETS        
Due from subsidiaries 225 1,824,782    
Liabilities:        
Other liabilities $ 1,831 $ 0